Moreover, with the acquisition of the transfusion medicine business of Pall Corporation for $551 million, Haemonetics has made its entry into the $1.2 billion whole blood collection market. This was followed by the company's acquisition of Hemerus Medical, a developer of technologies for the collection of whole blood. Haemonetics is optimistic about this acquisition and expects successful integration of the Hemerus SOLX collection system.